This report was first published by Endpoints News. To see the original version, click here
Steve Ubl, the leader of the drug industry’s powerful Washington, DC lobbying group PhRMA, will step down after more than a decade as CEO.
Endpoints News broke the news of his anticipated exit earlier Wednesday, and PhRMA confirmed Ubl’s plans in a statement later in the day.
您已阅读16%（365字），剩余84%（1952字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。